Literature DB >> 33293739

Social, cultural and economic aspects of antimicrobial resistance.

Timo Minssen1, Kevin Outterson2, Susan Rogers Van Katwyk3, Pedro Henrique D Batista4, Clare I R Chandler5, Francesco Ciabuschi6, Stephan Harbarth7, Aaron S Kesselheim8, Ramanan Laxminarayan9, Kathleen Liddell10, Michael T Osterholm11, Lance Price12, Steven J Hoffman3.   

Abstract

Entities:  

Year:  2020        PMID: 33293739      PMCID: PMC7716096          DOI: 10.2471/BLT.20.275875

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


× No keyword cloud information.
Although often considered only a medical problem, antimicrobial resistance is an evolutionary challenge accelerated by social, cultural and economic factors that lead to the misuse, overuse and abuse of life-saving antimicrobial medicines. The antimicrobial resistance challenge is compounded by inadequate attention to disease prevention and response, global circulation of people and products, differences in industry and market regulations across countries, and a fragile pipeline of new antibiotics and their alternatives. While the discovery of new antimicrobials will provide temporary solutions, sustainable success requires rigorous social science research that explores the drivers of antimicrobial resistance. These solutions should promote balance between equitable access to, conservation of, and innovation for antimicrobials, adapted to local conditions across the globe.– Effective actions against antimicrobial resistance will need to be informed by insights and evidence from the social sciences, encompassing a broad variety of disciplines. From our perspective, current engagement with the full range of social sciences is inadequate; greater collaboration within and between social science disciplines must be prioritized. Only then can we generate sufficient cross-sectional knowledge to overcome obstacles to addressing antimicrobial resistance, including inequitable access to effective antimicrobials, inadequate sanitation and hygiene infrastructure, disincentives for appropriate use of existing antimicrobials, and insufficient incentive for innovation in developing new antimicrobials. Collaboration among social scientists from various disciplines is also needed to help anticipate unintended consequences of action, such as inadvertently driving the use of suboptimal antibiotics by raising concerns about resistance., In the past 15 years, social science research has generated substantial knowledge about the systemic causes of antimicrobial resistance and has identified feasible interventions. After the World Health Assembly adopted the Global action plan on antimicrobial resistance in 2015, more than 120 countries developed national action plans. Despite this progress, challenges remain, such as how to scale-up access to antimicrobials without scaling-up resistance, identifying the clinical practices that can reduce antimicrobial use without risking lives, and how to de-link the price of antimicrobials from the cost of their development.– Existing global efforts may be too slow to counter antimicrobial resistance, given the lack of political commitment, the challenge of addressing transboundary collective action problems, and the difficulty in balancing antimicrobial resistance with other global threats. A range of social science disciplines can provide essential analytic tools for developing solutions for such global challenges. To encourage collaboration and to address this challenge, we have created the International Network for Antimicrobial Resistance Social Science (INAMRSS). The network is an open consortium of social science researchers focused on addressing the global challenge of antimicrobial resistance. We believe antimicrobial resistance is only surmountable through efforts that consider social, political and economic factors. We intend to champion social science as part of a broadly defined One Health perspective to inform global initiatives. INAMRSS is a member of the Global AMR R&D Hub stakeholder group, which has built a system to track antimicrobial resistance research investment, but has not yet started monitoring relevant social science research funding. We endorse the recommendation of the United Nations Interagency Coordination Group on Antimicrobial Resistance for creating an Independent Panel on Evidence for Action against such resistance, with appropriate expertise across disciplines including the social sciences, and with a focus on the ways that humans are driving this problem and can contribute to solutions. As initial steps, INAMRSS strongly recommends several coordinated initiatives to better identify and implement valuable social science insights to support and inform much needed action against antimicrobial resistance. These initiatives include (i) tracking inputs and outputs of social science research, including mapping current research spending, research publications and identifying key gaps; (ii) including social scientists in antimicrobial resistance research teams, panels, and proposals; (iii) exploring social science interventions to address antimicrobial resistance at individual, population and systemic levels; (iv) identifying key requirements for infrastructure support and international coordination, such as the Independent Panel on Evidence for Action Against Antimicrobial Resistance and the Global AMR R&D Hub; and (v) using the data generated above to appropriately fund social science research. Only when we consider the multidisciplinary aspects of the challenge together, will we prevail in addressing antimicrobial resistance.
  8 in total

1.  What Will It Take to Address the Global Threat of Antibiotic Resistance?

Authors:  Steven J Hoffman; Kevin Outterson
Journal:  J Law Med Ethics       Date:  2015       Impact factor: 1.718

2.  Improving antibiotic markets for long-term sustainability.

Authors:  Aaron S Kesselheim; Kevin Outterson
Journal:  Yale J Health Policy Law Ethics       Date:  2011

3.  How to improve antibiotic awareness campaigns: findings of a WHO global survey.

Authors:  Benedikt Huttner; Mirko Saam; Lorenzo Moja; Karen Mah; Marc Sprenger; Stephan Harbarth; Nicola Magrini
Journal:  BMJ Glob Health       Date:  2019-05-09

4.  Current accounts of antimicrobial resistance: stabilisation, individualisation and antibiotics as infrastructure.

Authors:  Clare I R Chandler
Journal:  Palgrave Commun       Date:  2019-05-21

5.  Knowing antmicrobial resistance in practice: a multi-country qualitative study with human and animal healthcare professionals.

Authors:  Maddy Pearson; Clare Chandler
Journal:  Glob Health Action       Date:  2019       Impact factor: 2.640

Review 6.  Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective.

Authors:  Stephan Harbarth; Werner Albrich; Christian Brun-Buisson
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

7.  The Consequences of AMR Education and Awareness Raising: Outputs, Outcomes, and Behavioural Impacts of an Antibiotic-Related Educational Activity in Lao PDR.

Authors:  Marco J Haenssgen; Thipphaphone Xayavong; Nutcha Charoenboon; Penporn Warapikuptanun; Yuzana Khine Zaw
Journal:  Antibiotics (Basel)       Date:  2018-11-01

Review 8.  Quick fix for care, productivity, hygiene and inequality: reframing the entrenched problem of antibiotic overuse.

Authors:  Laurie Denyer Willis; Clare Chandler
Journal:  BMJ Glob Health       Date:  2019-08-15
  8 in total
  3 in total

1.  Socio-cultural determinants of antibiotic resistance: a qualitative study of Greeks' attitudes, perceptions and values.

Authors:  Dimitrios Papadimou; Erik Malmqvist; Mirko Ancillotti
Journal:  BMC Public Health       Date:  2022-07-28       Impact factor: 4.135

2.  Exploring Farmers' Reasons for Antibiotic Use and Misuse in Pig Farms in Brazil.

Authors:  Rita Albernaz-Gonçalves; Gabriela Olmos; Maria José Hötzel
Journal:  Antibiotics (Basel)       Date:  2021-03-22

Review 3.  Linking Animal Welfare and Antibiotic Use in Pig Farming-A Review.

Authors:  Rita Albernaz-Gonçalves; Gabriela Olmos Antillón; Maria José Hötzel
Journal:  Animals (Basel)       Date:  2022-01-17       Impact factor: 2.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.